|
Volumn 33, Issue 4, 2003, Pages 755-764
|
HPLC-UV method development and validation for 16-dehydropregnenolone, a novel oral hypolipidaemic agent, in rat biological matrices for application to pharmacokinetic studies
|
Author keywords
Biomatrix; Dehydropregnenolonehypolipidaemic agents; Pharmacokinetics; Reversed phase chromatography
|
Indexed keywords
3 BETA HYDROXY 5,16 PREGNADIEN 20 ONE;
ANTILIPEMIC AGENT;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ARTICLE;
BLOOD SAMPLING;
CONTROLLED STUDY;
DIAGNOSTIC ACCURACY;
DRUG BLOOD LEVEL;
DRUG DETERMINATION;
DRUG DISTRIBUTION;
DRUG EXCRETION;
DRUG STORAGE;
DRUG STRUCTURE;
FECES ANALYSIS;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
MALE;
NONHUMAN;
PRIORITY JOURNAL;
QUANTITATIVE ANALYSIS;
RAT;
REVERSED PHASE LIQUID CHROMATOGRAPHY;
SEPARATION TECHNIQUE;
STRUCTURE ACTIVITY RELATION;
ULTRAVIOLET SPECTROPHOTOMETRY;
|
EID: 0242457511
PISSN: 07317085
EISSN: None
Source Type: Journal
DOI: 10.1016/S0731-7085(03)00308-X Document Type: Article |
Times cited : (12)
|
References (8)
|